Expression of retinoic acid receptors in normal, dysplastic and malignant oral epithelia

British Journal of Oral and Maxillofacial Surgery

Volumn 35, Issue 4, 1997, Pages 260-266

  Sherman, J A ^a   Partridge, M ^b  

^a ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; RETINOIC ACID DERIVATIVE; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMOPROPHYLAXIS; DYSPLASIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; MALIGNANT TRANSFORMATION; MOUTH CANCER; MOUTH MUCOSA;

EID: 0030864488     PISSN: 02664356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0266-4356(97)90044-9     Document Type: Article

References (24)

1. Wolbach SB, Howe PR. Tissue changes following deprivation of fat soluble A vitamin. J Exp Med 1925; 42: 753-778.
2. Fuchs E, Green H. Regulation of terminal differentiation of cultured human keratinocytes by vitamin A. Cell 1981; 25: 617-625.
3. Sporn M, Roberts A. The role of retinoids in differentiation and carcinogenesis. Cancer Res 1983; 43: 3034-3040.
4. Roberts AB, Sporn MB. The Retinoids. Orlando: Academic Press, 1984: 209.
5. Hong WK, Endicott J, Itri LM, Doos W, Batsakis JG, Bell R. 13 cis retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1986; 315: 1501-1505.
6. Lippman SM, Batsakis JG, Thoth BB. Comparison of low dose isotretinoin with beta carotene to prevent oral carcinogenesis. N Engl J Med 1993; 328: 15-20.
7. Busch C, Siegenthaler G, Vahlquist A, et al. Expression of cellular retinoid-binding proteins during normal and abnormal epidermal differentiation. J Invest Dermatol 1992; 99: 795-802.
8. Darmon M. The nuclear receptors of retinoic acid [Review]. J Lipid Mediators 1990; 2: 247-256.
9. Mangelsdorf D, Ong E, Dyck J, Evans R. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 1990; 345: 224-229.
10. Noji S, Yamaai T, Koyama E et al. Expression of retinoic acid receptor genes in keratinising front of skin. FEBS Lett 1989; 269: 86-90.
11. Kastner P, Krust A, Mendelsohn C et al. Murine isoforms of retinoic acid receptor γ with specific patterns of expression. Proc Natl Acad Sci 1990; 87: 2700-2704.
12. Elder JT, Fisher GJ, Zhang Q-Y et al. Retinoic acid receptor gene expression in human skin. J Invest Dermatol 1991; 96: 425-433.
13. Hu L, Crowe DL, Rheinwald JG, Chambon P, Gudas LJ. Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Cancer Res 1991; 51: 3972-3981.
14. Xu X-C, Ro JY, Lee JS, Shin DM, Hong WK, Lotan R. Differential expression of nuclear retinoid receptors in normal, premalignant and malignant head and neck tissues. Cancer Res 1994; 54: 3580-3587.
15. Gaub MP, Lutz Y, Ruberte E et al. Antibodies specific to the retinoic acid human nuclear receptors α and β. Proc Natl Acad Sci 1989; 86: 3089-3093.
16. Langdon JD, Partridge M. Expression of the tumour suppressor gene p53 in oral cancer. Br J Oral & Maxillofacial Surg 1992; 30: 214-220.
17. Rees JL, Redfern CPF. Expression of the alpha and beta retinoic acid receptors in the skin. J Invest Dermatol 1989; 93: 818-820.
18. Tavakkol A, Griffiths CEM, Keane KM, Palmer RD, Voorhees JJ. Cellular localization of mRNA for cellular retinoic acid-binding protein II and nuclear retinoic acid receptor-γ1 in retinoic acid-treated human skin. J Invest Dermatol 1992; 99: 146-150.
19. Kautsky MB, Fleckman P, Dale BA. Retinoic acid regulates oral epithelial differentiation by two mechanisms. J Invest Dermatol 1995; 104: 546-553.
20. Lotan R, Xu X-C, Lippman S et al. Suppression of Retinoic acid receptor B in premalignant oral lesions and its up-regulation by isotretinoin. New Engl J Med 1995; 332: 1405-1410.
21. Partridge M, Smith C, Green M. Differences between the distribution of epidermal growth factor receptor in human skin and oral mucosa, detected by immunohistochemistry and EGF binding studies. Epithelia 1988; 1: 179-1.
22. Lippman SM, Kessler JF, Al-Sarraf M et al. Treatment of advanced squamous cell carcinoma of the head and neck with isotretinoin: a phase 11 randomised trial. Invest New Drugs 1988; 6: 13-17.
23. Jetten AM, Kim JS, Sacks PG et al. Inhibition of growth and differentiation markers in cultured human head and neck squamous carcinoma cells by all trans retinoic acid. Int J Cancer 1990; 45: 195-202.
24. Hong WK, Doos WG. Chemoprevention of head and neck cancer: potential use of retinoids. Otolaryngol Clin North Am 1985; 18: 543-549.